Drug screening identifies tazarotene and bexarotene as therapeutic agents in Multiple Sulfatase Deficiency. Drug screening identifies tazarotene and bexarotene as therapeutic agents in Multiple Sulfatase Deficiency
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA846323
下载链接
链接失效反馈官方服务：
资源简介：
We analysed differences in gene expression upon treatment of MSD patient fibroblast lines with either tazarotene or adapalene and DMSO control (untreated condition) Overall design: Comparative gene expression profiling analysis of RNA-seq data
创建时间：
2022-06-06
